Skip to content
The Nexus
DossierENTITY

Emergent Biosolutions Inc.

Coverage of Emergent Biosolutions Inc. in the Nexus archive.

Earliest in view: Aug 5 · 20:30 UTCMost recent: Aug 5 · 20:30 UTC
Co-mentioned in this coverage
Recent coverage
  • BUSINESSAug 5 · 20:30 UTCWTOP DC
    Emergent Biosolutions: Q2 Earnings Snapshot

    Emergent Biosolutions Inc. reported a second-quarter loss of $180.2 million, or $3.49 per share, with adjusted earnings of 60 cents per share. The company's revenue for the period was $234.3 million.

Emergent Biosolutions Inc. · Dossier · The Nexus